Tyra Biosciences, Inc. (TYRA) stock
TYRANasdaqPharmaceutical PreparationsFiscal year ends December 31
$19.57−0.17 (-0.86%)
Close on Nov 17, 2026Market cap $1.17BP/E –Yield –
Tyra Biosciences total assets
Total assets on the balance sheet at the end of each period.
Tyra Biosciences's total assets was $383.36M at Jun 30, 2026. For fiscal 2025 it was $282.61M, down 22.3% from the year before. The highest annual figure on record is $363.56M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $282.61M | -22.3% |
| FY2024 | Dec 31, 2024 | $363.56M | +61.0% |
| FY2023 | Dec 31, 2023 | $225.86M | -15.1% |
| FY2022 | Dec 31, 2022 | $266.18M | -13.2% |
| FY2021 | Dec 31, 2021 | $306.70M | +1815.6% |
| FY2020 | Dec 31, 2020 | $16.01M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $383.36M | +19.2% |
| Q1 FY2026 | Mar 31, 2026 | $412.04M | +20.0% |
| Q4 FY2025 | Dec 31, 2025 | $282.61M | -22.3% |
| Q3 FY2025 | Sep 30, 2025 | $301.85M | -20.7% |
| Q2 FY2025 | Jun 30, 2025 | $321.50M | -18.1% |
| Q1 FY2025 | Mar 31, 2025 | $343.48M | -15.1% |
| Q4 FY2024 | Dec 31, 2024 | $363.56M | +61.0% |
| Q3 FY2024 | Sep 30, 2024 | $380.59M | +59.7% |
| Q2 FY2024 | Jun 30, 2024 | $392.46M | +57.0% |
| Q1 FY2024 | Mar 31, 2024 | $404.74M | +58.7% |
| Q4 FY2023 | Dec 31, 2023 | $225.86M | -15.1% |
| Q3 FY2023 | Sep 30, 2023 | $238.36M | -13.6% |
| Q2 FY2023 | Jun 30, 2023 | $250.01M | -12.9% |
| Q1 FY2023 | Mar 31, 2023 | $255.06M | -14.7% |
| Q4 FY2022 | Dec 31, 2022 | $266.18M | -13.2% |
| Q3 FY2022 | Sep 30, 2022 | $275.99M | -12.7% |
| Q2 FY2022 | Jun 30, 2022 | $287.12M | +1693.3% |
| Q1 FY2022 | Mar 31, 2022 | $298.97M | – |
| Q4 FY2021 | Dec 31, 2021 | $306.70M | – |
| Q3 FY2021 | Sep 30, 2021 | $315.97M | – |
| Q4 FY2020 | Dec 31, 2020 | $16.01M | – |
See a number that looks wrong?